An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.

Decades ago, the FDA approved the use of two prescription medicines — mifepristone and misoprostol — to terminate ... performed each month in states that either ban abortion totally or after six weeks ...

Over the years, the FDA has removed some restrictions on mifepristone. In 2016, it extended its use from seven to 10 weeks into pregnancy. In 2019, it approved a generic version of the medication.

For those unfamiliar with the medication, the FDA approved mifepristone about a quarter of a century ago, to be used as part of a two-step process to terminate unwanted pregnancies up to 10 weeks.

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues … ...

FDA Commissioner Marty Makary wrote a letter to pro-life Senator Josh Hawley (R., Mo.) Monday informing him of the agency’s plan to conduct a review of mifepristone.

Mifepristone, subject to continuous debate since FDA approval in 2000, has become emblematic of a larger trend where bureaucratic safeguards are sidelined in favor of market expediency and ...

The FDA approved mifepristone without any evidence about how it would affect minors, even though it was to be prescribed for all pregnant females. The FDA’s approval, however, still came with ...